Matches in SemOpenAlex for { <https://semopenalex.org/work/W2506475006> ?p ?o ?g. }
- W2506475006 endingPage "232" @default.
- W2506475006 startingPage "195" @default.
- W2506475006 abstract "A summary is provided of the compelling data supporting galectin-3, as a target for cancer therapy, and for the clinical development of a truncated form of human galectin-3, termed galectin-3C, for cancer. Lacking the N-terminal domain of galectin-3 that facilitates its multimerization when bound to carbohydrate ligands, galectin-3C functions as an inhibitor of the galectin-3 crosslinking mediated by the N-terminal domain that can be induced by multivalent oligosaccharides and glycoconjugates intra- or extracellularly, on cell surfaces, or in extracellular matrices. Numerous studies show that galectin-3 plays a key role in tumorigenicity and metastasis and is a novel target for the development of cancer therapeutics. Data presented indicate that galectin-3C can be localized in a carbohydrate-dependent manner similar to most information reported regarding galectin-3. Exogenous galectin-3C facilitated anoikis in human breast cells, illustrating an effect it is expected to produce in vivo by reducing cell-cell or cell-ECM adhesion of metastatic cells. Based on the activity of galectin-3, we postulate that galectin-3C also inhibits the metastatic process by preventing integrin activation and focal adhesion turnover. The data described provide evidence of the important functions of galectin-3 in the processes of metastasis and tumorigenicity, and the potential therapeutic effect of inhibiting the activity of galectin-3 with galectin-3C. Galectin-3 has a complex, multi-faceted role that is critical in the relationship between the cells of various types of malignancies and the microenvironment, and further development of galectin-3C as a clinical candidate for cancer treatment is warranted." @default.
- W2506475006 created "2016-08-23" @default.
- W2506475006 creator A5015010568 @default.
- W2506475006 creator A5022084686 @default.
- W2506475006 creator A5035234881 @default.
- W2506475006 creator A5043523278 @default.
- W2506475006 creator A5052437060 @default.
- W2506475006 creator A5077243530 @default.
- W2506475006 date "2012-01-01" @default.
- W2506475006 modified "2023-09-25" @default.
- W2506475006 title "Galectin-3C: Human Lectin for Treatment of Cancer" @default.
- W2506475006 cites W1514367558 @default.
- W2506475006 cites W1515087876 @default.
- W2506475006 cites W1531421007 @default.
- W2506475006 cites W1536370890 @default.
- W2506475006 cites W1576409652 @default.
- W2506475006 cites W1964461360 @default.
- W2506475006 cites W1966895889 @default.
- W2506475006 cites W1968460133 @default.
- W2506475006 cites W1969299596 @default.
- W2506475006 cites W1972819616 @default.
- W2506475006 cites W1976557192 @default.
- W2506475006 cites W1980434442 @default.
- W2506475006 cites W1984182024 @default.
- W2506475006 cites W1985324057 @default.
- W2506475006 cites W198570261 @default.
- W2506475006 cites W1986363398 @default.
- W2506475006 cites W1990007130 @default.
- W2506475006 cites W1990375972 @default.
- W2506475006 cites W1991509596 @default.
- W2506475006 cites W1994184760 @default.
- W2506475006 cites W1995243908 @default.
- W2506475006 cites W1995294053 @default.
- W2506475006 cites W1996219643 @default.
- W2506475006 cites W1997261925 @default.
- W2506475006 cites W2000245188 @default.
- W2506475006 cites W2001819260 @default.
- W2506475006 cites W2001950447 @default.
- W2506475006 cites W2002534521 @default.
- W2506475006 cites W2003128631 @default.
- W2506475006 cites W2006832551 @default.
- W2506475006 cites W2007125271 @default.
- W2506475006 cites W2007939915 @default.
- W2506475006 cites W2010016099 @default.
- W2506475006 cites W2010896383 @default.
- W2506475006 cites W2012744533 @default.
- W2506475006 cites W2016235652 @default.
- W2506475006 cites W2024477019 @default.
- W2506475006 cites W2025381360 @default.
- W2506475006 cites W2027039566 @default.
- W2506475006 cites W2027589717 @default.
- W2506475006 cites W2029756209 @default.
- W2506475006 cites W2031054438 @default.
- W2506475006 cites W2049185890 @default.
- W2506475006 cites W2052315444 @default.
- W2506475006 cites W2053923614 @default.
- W2506475006 cites W2056498704 @default.
- W2506475006 cites W2058412130 @default.
- W2506475006 cites W2066545420 @default.
- W2506475006 cites W2069883829 @default.
- W2506475006 cites W2076754615 @default.
- W2506475006 cites W2077459192 @default.
- W2506475006 cites W2078534859 @default.
- W2506475006 cites W2080487942 @default.
- W2506475006 cites W2086867157 @default.
- W2506475006 cites W2091294161 @default.
- W2506475006 cites W2092457960 @default.
- W2506475006 cites W2106161218 @default.
- W2506475006 cites W2107471867 @default.
- W2506475006 cites W2107691432 @default.
- W2506475006 cites W2107971382 @default.
- W2506475006 cites W2119494676 @default.
- W2506475006 cites W2121313275 @default.
- W2506475006 cites W2121378879 @default.
- W2506475006 cites W2121681121 @default.
- W2506475006 cites W2124377923 @default.
- W2506475006 cites W2129380686 @default.
- W2506475006 cites W2130574102 @default.
- W2506475006 cites W2130963723 @default.
- W2506475006 cites W2136715985 @default.
- W2506475006 cites W2141309671 @default.
- W2506475006 cites W2143021530 @default.
- W2506475006 cites W2145426123 @default.
- W2506475006 cites W2147667971 @default.
- W2506475006 cites W2150280909 @default.
- W2506475006 cites W2150742225 @default.
- W2506475006 cites W2155181742 @default.
- W2506475006 cites W2159203705 @default.
- W2506475006 cites W2161932747 @default.
- W2506475006 cites W2169146746 @default.
- W2506475006 cites W2170273692 @default.
- W2506475006 cites W2171417360 @default.
- W2506475006 cites W2287013995 @default.
- W2506475006 cites W4245953818 @default.
- W2506475006 doi "https://doi.org/10.1021/bk-2012-1115.ch012" @default.
- W2506475006 hasPublicationYear "2012" @default.
- W2506475006 type Work @default.
- W2506475006 sameAs 2506475006 @default.